Achieving Success with New Technology Add-on Payment (NTAP): What Life Sciences Companies Need to Know

This webinar is designed for life sciences companies seeking to navigate the New Technology Add-on Payment (NTAP) program. This session will equip drug, device, and diagnostic manufacturers with a clear understanding of eligibility requirements, the application process, and how to strategically position products for approval. Experts from HMA and Manatt Health will also break down CMS evaluation criteria and highlight key updates shaping the NTAP program in 2026 and 2027.

Learning Objectives:

• Understand NTAP eligibility requirements and the end-to-end application process
• Learn how CMS evaluates applications and what drives approval decisions
• Explore key updates and policy changes impacting NTAP in 2026 and 2027

Speakers:

• Clare Mamerow, Principal, Health Management Associates
• Ross Margulies, Partner, Manatt Health